Abstract
We examined serum copper (Cu), serum zinc (Zn), and the serum copper/zinc ratio (Cu/Zn) in 162 patients. All of them were seen to have an abnormal shadow in the chest X-ray films, that is, 109 patients with lung cancer (LC) and 53 patients with no lung cancer (NLC). The mean Cu and Cu/Zn in LC patients were significantly higher than those in NLC patients (p<0.05). In LC patients, Cu and Cu/Zn were higher and Zn was lower in advanced tumors than early ones. There was a significantly clear relation between Cu or Cu/Zn and the tumor (T) stages. When the relative risk (RR) of LC was estimated, it was seen that the higher Cu and Cu/Zn became, the higher RR became. Furthermore, we showed the sensitivity of the receiver operator characteristic of the test (ROC) curve for Cu, Cu/Zn, and carcinoembryonic antigen (CEA) to diagnose LC, as explained in a paragraph of methods.The determinations of Cu, Zn, and Cu/Zn are simple and inexpensive. They also appear to have a great diagnostic value in determining the local invasion of LC and as a screening test in the high-risk patients for LC.
Similar content being viewed by others
References
J. A. Halsted and J. C. Smith,Lancet 1, 322–325 (1970).
M. K. Schwartz,Cancer Res. 35, 3481–3487 (1975).
Y. Cohen, R. Epelbaum, N. Haim, D. McShan, and O. Zinder,Cancer 53, 296–300 (1984).
M. Hrgovic, C. F. Tessmer, F. B. Thomas, L. M. Fuller, J. F. Gamble, and C. G. Shullembarger,Cancer 31, 1337–1345 (1976).
I. Shah, L. M. Lewkow, and V. Khilanani,Cancer 51, 851–854 (1983).
A. Lightman, J. M. Brandes, N. Binus, A. Drugan, and O. Zinder,Clin. Chem. 32, 101–103 (1986).
E. J. Margalioth, R. Udassin, J. Maor, and J. G. Schenker,Cancer 56, 856–859 (1985).
E. Huhti, A. Poukkula, and E. Uksila,Respiration 40, 112–116 (1980).
G. S. Andrews,J. Clin. Pathol. 32, 325–333 (1980).
S. Inutsuka and S. Araki,Cancer 42, 626–631 (1978).
B. F. Issel, B. V. MacFadyen, E. T. Gum, M. Valdivieso, S. J. Dudrick, and G. P. Bodey,Cancer 47, 1845–1848 (1981).
M. C. Linder, J. R. Moor, and K. Wright,J. Natl. Cancer Inst. 67, 263–275 (1981).
J. A. Garofalo, H. Ashikari, M. L. Lesser, C. Menendez-Botet, S. Cunningham-Rundles, M. K. Schwartz, and R. A. Good,Cancer 46, 2682–2685 (1980).
R. Gorodetsky, Z. V. Fuks, A. Sulkes, H. Ginsburg, and Z. Weshler,Cancer 55, 779–787 (1985).
B. N. Gray, G. Walker, and R. Barnard,J. Surg. Oncol. 21, 230–232 (1982).
O. Miatto, M. Casaril, G. Gabrielli, N. Nicolli, G. Bellisola, and R. Corrocher,Cancer 55, 774–778 (1985).
W. Merts,Fed. Proc. 41, 2807–2812 (1982).
M. Dìez, F. J. Cerdàn, M. Arroyo, and J. L. Balibrea,Cancer 63, 726–730 (1989).
P. Gold and S. O. Freedman,J. Exp. Medal 121, 439–471 (1965).
J. P. Concannon, M. H. Dalbow, S. E. Hodgson, J. J. Headings, E. Markopoulos, J. Mitchell, W. J. Cushing, and G. A. Liebler,Cancer 42, 1477–1483 (1978).
T. C. Stokes, F. S. Stevens, P. Long, E. Lockey, and A. L. Miller,Br. J. Dis. Chest 74, 390–394 (1980).
T. Shinkai, N. Saijo, K. Tominaga, K. Eguchi, E. Shimizu, Y. Sakaki, J. Fujita, H. Futami, H. Ohkura, and K. Suemasu,Cancer 57, 1318–1323 (1986).
C. Gropp, K. Havemann, and F.-G. Lehmann,Cancer 42, 2802–2808 (1978).
C. F. Mountain,Chest 89 (suppl.), 225s-233s (1986).
World Health Organization,Am. J. Clin. Pathol. 77, 123–136 (1982).
SAS Institute Inc., inSAS/STAT ™ User's Guide, Release 6.03 ed., Cary, NC, pp. 189–282, 549–640 (1988).
G. E. Cartwright and M. M. Wintrobe,Am. J. Clin. Nutr. 14, 224–232 (1964).
L. M. Klevay,Am. J. Clin. Nutr. 28, 764–774, (1975).
L. M. Klevay,Ann. NY Acad. Sci. 355, 140–151 (1980).
W. K. Canfield, K. M. Hambidge, and L. K. Johnson,J. Pediatr. Gastroenterol. Nutr. 3, 577–584 (1984).
O. S. Atic,J. Am. Geriatr. Soc. 31, 790–791 (1983).
J. N. Logue, M. D. Koontz, and M. A. Hattwick,J. Occup. Med. 24, 398–408 (1982).
J. A. Newman, V. E. Archer, G. Saccomanno, M. Kuschner, O. Auerbach, R. D. Grondahl, and J. C. Wilson,Ann. NY Acad. Sci. 271, 260–268 (1976).
L. Gerhardson, D. Brune, G. F. Nordberg, and P. O. Wester,Sci. Total Environ. 50, 65–85 (1986).
A. F. Parisi and B. L. Vallee,Biochemistry 9, 2421–2427 (1970).
E. L. Giroux and R. I. Henkin,Biochim. Biophys. Acta. 273, 64–72 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oyama, T., Matsuno, K., Kawamoto, T. et al. Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer. Biol Trace Elem Res 42, 115–127 (1994). https://doi.org/10.1007/BF02785383
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02785383